Build Your Workforce
Industry - Healthcare and life sciences

Market intelligence for healthcare and life sciences.

This industry inverts the usual weighting. Filings and regulatory submissions are rich, detailed and dated. Pricing is negotiated and rarely posted. Hiring moves slowly enough that a cluster means something different from what it means in software.

Explore DemoSee pricing
The problem

The events that change a commercial picture here - an approval, a submission, a trial milestone, a partnership - are all announced somewhere dated and checkable, and they are buried in document sets nobody has time to read weekly. Meanwhile the signals that work elsewhere, particularly posted pricing, barely exist.

What arrives
  • Filings and regulatory events per watched company, dated, with the document behind each
  • Announcements and partnerships, deduplicated so one event counts once
  • A readable history from the first day rather than from the day you started watching
  • The decision makers a document actually names, and silence where none does
  • Excel, CSV, PDF or slides of any of it (Excel only on Starter)
Who does the work

The agents on the job, in the order they work

  1. 01 · Regulator

    Reads regulatory filings and registers, which in this industry carry more of the real change than any other source.

  2. 02 · Scout

    Reads company announcements and investor pages, where approvals, submissions and partnerships appear first.

  3. 03 · Historian

    Reads backwards, so a company’s dated trail is readable on day one rather than starting the day you added it.

  4. 04 · Sifter

    Holds back the volume. An approval reported by nine outlets is one event, and the log shows what was set aside.

What it does not do
  • Pricing intelligence is weak here and the workspace does not pretend otherwise. Prices in this industry are negotiated, not posted.
  • Hiring signals are slower and noisier than in software. A cluster that would be decisive for a SaaS account often is not here.
  • It reads what is on the record. It makes no clinical, scientific or investment judgement about anything it reads, and it is not investment advice.
Which plan

Every lens is available on every plan. Starter watches 10 companies, checked weekly; Growth watches 40, every six hours; Enterprise watches 60.

Questions

What people ask

Does it read clinical trial registries?
It reads the filings and announcements that carry trial milestones and regulatory events, with the source attached. It does not evaluate the science, and a system that offered to would be overstepping what open evidence supports.
Why is the pricing lens weak in this industry?
Because the prices are not posted. Almost everything is negotiated through payers, procurement or tender, none of which is public. A pricing view built from open evidence would be mostly empty here, and an empty view stated honestly is better than an inferred one.
Is it useful if my market is providers rather than manufacturers?
Partly. Provider organisations hire openly, which restores one strong signal, and many post procurement notices. The filing-led picture that makes this industry work is thinner on the provider side.
Related

Read next

Know which new rules land on your accounts, and when they take effect.Read →Market research in minutes, with a source on every figure.Read →Market intelligence for industrial and manufacturing, including where it falls short.Read →

See it on your own market.

A working demo on the companies you actually care about, not a recorded video.

Explore DemoBuild Your Workforce